1. Recent Advances in Gynecological Malignancies: Focus on ASCO 2023

   • Olga Bodriagova
   • Rebecca Ann Previs
   • Kamal S. Saini

   Editorial Open access 15 September 2023 Pages: 397 - 409

2. Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast

   • Brian Dong
   • Rita Lusen
   • Lisa Kline

   Commentary Open access 29 September 2023 Pages: 411 - 418

   

3. EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists

   • Stephen V. Liu
   • Ivy B. Elkins
   • Sarah B. Goldberg

   Commentary Open access 26 September 2023 Pages: 419 - 431

4. Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast

   • Reva Basho
   • Megan-Claire Chase

   Commentary Open access 14 September 2023 Pages: 433 - 443

   

5. The Landscape of BRCA Mutations among Egyptian Women with Breast Cancer

   • Hamdy A. Azim
   • Samah A. Loutfy
   • Loay Kassem

   Review Open access 20 September 2023 Pages: 445 - 459

   

6. A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral Cancers

   • Karthik Nagaraja Rao
   • Ripudaman Arora
   • Alfio Ferlito

   Review Open access 07 October 2023 Pages: 461 - 480

   

7. Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer

   • Sandhya Mehta
   • Jipan Xie
   • Winghan J. Kwong

   Original Research Open access 16 September 2023 Pages: 481 - 493

   

8. Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma

   • Javier Sanchez Alvarez
   • Mahmoud Jaber
   • Marie-Hélène Blanchet Zumofen

   Original Research Open access 18 October 2023 Pages: 495 - 511

   

9. Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer

   • Naama Halpern
   • Ben Boursi
   • Eyal Leshem

   Brief Report Open access 21 October 2023 Pages: 513 - 519